| 000 | 01634 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518044246.0 | ||
| 264 | 0 | _c20200527 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1559-2308 | ||
| 024 | 7 |
_a10.1080/15592294.2019.1629231 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSutton, Laura P | |
| 245 | 0 | 0 |
_aDNA methylation changes following DNA damage in prostate cancer cells. _h[electronic resource] |
| 260 |
_bEpigenetics _c10 2019 |
||
| 300 |
_a989-1002 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAzacitidine _xpharmacology |
| 650 | 0 | 4 |
_aBRCA1 Protein _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCpG Islands _xdrug effects |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
| 650 | 0 | 4 |
_aEpigenesis, Genetic _xdrug effects |
| 650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPC-3 Cells |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRadiation Tolerance |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 700 | 1 | _aJeffreys, Sarah A | |
| 700 | 1 | _aPhillips, Jessica L | |
| 700 | 1 | _aTaberlay, Phillippa C | |
| 700 | 1 | _aHolloway, Adele F | |
| 700 | 1 | _aAmbrose, Mark | |
| 700 | 1 | _aJoo, Ji-Hoon E | |
| 700 | 1 | _aYoung, Arabella | |
| 700 | 1 | _aBerry, Rachael | |
| 700 | 1 | _aSkala, Marketa | |
| 700 | 1 | _aBrettingham-Moore, Kate H | |
| 773 | 0 |
_tEpigenetics _gvol. 14 _gno. 10 _gp. 989-1002 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/15592294.2019.1629231 _zAvailable from publisher's website |
| 999 |
_c29807395 _d29807395 |
||